Estrategias terapéuticas en el síndrome antifosfolipídico

2002 Bucciarelli, 2006, Mortality in the catastrophic antiphospholipid syndrome. Causes of death and prognostic factors in a series of 250 patients, Arthritis Rheum, 54, 2568, 10.1002/art.22018 Alarcón-Segovia, 2003, Prophylaxis of the antiphospholipid syndrome: A consensus report, Lupus, 12, 499, 10.1191/0961203303lu388oa Ginsburg, 1992, Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis, Ann Intern Med, 117, 997, 10.7326/0003-4819-117-12-997 Erkan, 2007, Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: A randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals, Arthritis Rheum, 56, 2382, 10.1002/art.22663 Wahl, 2000, Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholpid antibodies, Arch Intern Med, 160, 2042, 10.1001/archinte.160.13.2042 Erkan, 2001, High thrombosis rate after fetal loss in antiphospholipid syndrome: Effective prophylaxis with aspirin, Arthritis Rheum, 44, 1466, 10.1002/1529-0131(200106)44:6<1466::AID-ART242>3.0.CO;2-C Ruiz-Irastorza, 2006, Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus, Lupus, 15, 577, 10.1177/0961203306071872 Font J, Cervera R, Ramos-Casals M, Espinosa G, Jiménez S, Ingelmo M. Guías clínicas 2006-Diagnóstico y tratamiento de las enfermedades autoinmunes sistémicas. 3.a ed. Barcelona: MRA; 2006. Rosove, 1992, Antiphospholipid thrombosis: Clinical course after the first thrombotic event in 70 patients, Ann Intern Med, 117, 303, 10.7326/0003-4819-117-4-303 Khamashta, 1995, The management of thrombosis in the antiphospholipid antibody syndrome, N Engl J Med, 332, 993, 10.1056/NEJM199504133321504 Derksen, 1993, Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment, Ann Rheum Dis, 52, 689, 10.1136/ard.52.9.689 Rance, 1997, Anticardiolipin antibodies and recurrent thromboembolism, Thromb Haemost, 77, 221, 10.1055/s-0038-1655939 Schulman, 1998, Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy, Am J Med, 104, 332, 10.1016/S0002-9343(98)00060-6 Crowther, 2003, A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome, N Engl J Med, 349, 1133, 10.1056/NEJMoa035241 Castellino, 2001, Characteristics of patients with antiphospholipid syndrome with major bleeding after oral anticoagulant treatment, Ann Rheum Dis, 60, 527, 10.1136/ard.60.5.527 Brunner, 2002, Longterm anticoagulation is preferable for patients with antiphospholipid syndrome. Result of a decision analysis, J Rheumatol, 29, 490 Meroni, 2003, Venous thromboembolism in the antiphospholipid syndrome: Management guidelines for secondary prophylaxis, Lupus, 12, 504, 10.1191/0961203303lu389oa Ruiz-Irastorza, 2007, A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies, Arthritis Rheum, 57, 1487, 10.1002/art.23109 Albers, 1999, Antiplatelet therapy: New foundations for optimal treatment decisions, Neurology, 53, 25 Levine, 1997, IgG anticardiolipin antibody titers > 40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study, Stroke, 28, 1660, 10.1161/01.STR.28.9.1660 Verro, 1998, Cerebrovascular ischemic events with high positive anticardiolipin antibodies, Stroke, 29, 2245, 10.1161/01.STR.29.11.2245 Jacobs, 2000, Antiphospholipid antibody syndrome, Curr Treat Options Neurol, 2, 449, 10.1007/s11940-000-0043-9 Levine, 2002, The antiphospholipid syndrome, N Engl J Med, 346, 752, 10.1056/NEJMra002974 1998, BCSH guidelines on oral anticoagulation, Br J Haematol, 101, 374, 10.1046/j.1365-2141.1998.00715.x Cervera R, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Kiss E, et al. Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: A multicenter prospective study of 1,000 patients. Ann Rheum Dis. 2008 Sep 18. [Epub ahead of print]. Asherson, 2002, Catastrophic antiphospholipid syndrome: Proposed guidelines for diagnosis and treatment, J Clin Rheumatol, 8, 157, 10.1097/00124743-200206000-00008 Asherson, 2000, The catastrophic antiphospholipid antibody syndrome: A review of pathogenesis, clinical features and treatment, IMAJ, 2, 268 Asherson, 2001, Catastrophic antiphospholipid syndrome: Clues to the pathogenesis from a series of 80 patients, Medicine (Baltimore), 80, 355, 10.1097/00005792-200111000-00002 Neuwelt, 1997, Catastrophic antiphospholipid syndrome: Response to repeated plasmapheresis over three years, Arthritis Rheum, 40, 1534, 10.1002/art.1780400823 Asherson, 1998, Catastrophic antibody syndrome. Clinical and laboratory features of 50 patients, Medicine (Baltimore), 77, 195, 10.1097/00005792-199805000-00005 Kitchens, 1998, Thrombotic storm: When thrombosis begets thrombosis, Am J Med, 104, 381, 10.1016/S0002-9343(98)00061-8 Kane, 1998, Catastrophic antiphospholipid antibody syndrome in primary systemic sclerosis, J Rheumatol, 25, 810 Dosekun, 1984, Ancrod in systemic lupus erythematosus with thrombosis. Clinical and fibrinolysis effects, Arch Intern Med, 144, 37, 10.1001/archinte.1984.00350130043009 Asherson, 2003, Catastrophic antiphosphospholipid syndrome: International consensus statement on classification criteria and treatment guidelines, Lupus, 12, 530, 10.1191/0961203303lu394oa Shehata, 2001, Management of pregnancy in antiphospholipid syndrome, Rheum Dis Clin North Am, 27, 643, 10.1016/S0889-857X(05)70226-X Kutteh, 1996, Antiphospholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone, Am J Obstet Gynecol, 174, 1584, 10.1016/S0002-9378(96)70610-5 Rai, 1997, Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies, BMJ, 314, 253, 10.1136/bmj.314.7076.253 Farquharson, 2002, Antiphospholipid syndrome in pregnancy: A randomized controlled trial of treatment, Obstet Gynecol, 100, 408, 10.1016/S0029-7844(02)02165-8 Silver, 1993, Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients, Am J Obstet Gynecol, 169, 1411, 10.1016/0002-9378(93)90410-K Pattison, 2000, Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial, Am J Obstet Gynecol, 183, 1008, 10.1067/mob.2000.106754 Tincani, 2003, Treatment of pregnant patients with antiphospholipid syndrome, Lupus, 12, 524, 10.1191/0961203303lu393oa Balasch, 1993, Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome, Hum Reprod, 8, 2234, 10.1093/oxfordjournals.humrep.a138009 Carmona, 2001, Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: A multivariate analysis, Am J Reprod Immunol, 46, 274, 10.1034/j.1600-0897.2001.d01-13.x Branch, 2000, A multicenter, placebo-controlled pilot study of intravenous immunoglobulin treatment of antiphospholipid syndrome during pregnancy, Am J Obstet Gynecol, 182, 122, 10.1016/S0002-9378(00)70500-X Sanson, 1999, Safety of low-molecular weight heparin in pregnancy: A systematic review, Thromb Haemost, 81, 668, 10.1055/s-0037-1614550 Font, 2000, Splenectomy for refractory Evans′ syndrome associated with antiphospholipid antibodies: Report of two cases, Ann Rheum Dis, 59, 920, 10.1136/ard.59.11.920 García-Carrasco, 2008, Use of rituximab in patients with systemic lupus erythematosus: An update, Autoimmun Rev, 8, 343, 10.1016/j.autrev.2008.11.006 Lockshin, 2003, Cardiac disease in the antiphospholipid syndrome: Recommendations for treatment. Committee consensus report, Lupus, 12, 518, 10.1191/0961203303lu391oa